Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
H3F3A | HIST1H3A | HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, | 3.55E4 | Evidence | |||||
H3F3A | H2AFX | H2AFX, H2AX: Histone H2A.x | 8.73E3 | Evidence | |||||
H3F3A | GCN5L2 | GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 | 7.90E3 | Evidence | |||||
H3F3A | HIST1H4A | HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H | 4.55E3 | Evidence | |||||
H3F3A | PCAF | PCAF: Histone acetyltransferase PCAF | 4.17E3 | Evidence | |||||
H3F3A | SF3B1 | SF3B1, SAP155: Splicing factor 3B subunit 1 | 4.08E3 | Evidence | |||||
H3F3A | HIST2H2BE | HIST2H2BE, H2BFQ: Histone H2B type 2-E | 4.06E3 | Evidence | |||||
H3F3A | HIST2H2AC | HIST2H2AC, H2AFQ: Histone H2A type 2-C | 717.0 | Evidence | |||||
H3F3A | PRKAA2 | PRKAA2, AMPK, AMPK2: 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 403.0 | Evidence | |||||
H3F3A | ASF1A | ASF1A, CGI-98, HSPC146: Histone chaperone ASF1A | 379.0 | Evidence | |||||
H3F3A | TP53 | TP53, P53: Cellular tumor antigen p53 | 304.0 | Evidence | |||||
H3F3A | HIST1H2BD | HIST1H2BD, H2BFB, HIRIP2: Histone H2B type 1-D | 162.0 | Evidence | |||||
H3F3A | HIRA | HIRA, DGCR1, HIR, TUPLE1: Protein HIRA | 85.40 | Evidence | |||||
H3F3A | CORO1C | CORO1C, CRNN4: Coronin-1C | 85.40 | Evidence | |||||
H3F3A | RBBP4 | RBBP4, RBAP48: Histone-binding protein RBBP4 | 85.40 | Evidence | |||||
H3F3A | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 85.40 | Evidence | |||||
H3F3A | EP300 | N/A | 84.00 | Evidence | |||||
H3F3A | BRD3 | BRD3, KIAA0043, RING3L: Bromodomain-containing protein 3 | 43.10 | Evidence | |||||
H3F3A | TAF6 | TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 | 39.10 | Evidence | |||||
H3F3A | YY1 | YY1: Transcriptional repressor protein YY1 | 38.20 | Evidence | |||||
H3F3A | COPB2 | COPB2: Coatomer subunit beta' | 38.10 | Evidence | |||||
H3F3A | NBN | NBN, NBS, NBS1, P95: Nibrin | 36.00 | Evidence | |||||
H3F3A | SAT | SAT1, SAT: Diamine acetyltransferase 1 | 34.90 | Evidence | |||||
H3F3A | BAZ2A | BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A | 33.90 | Evidence | |||||
H3F3A | TCF20 | TCF20, KIAA0292, SPBP: Transcription factor 20 | 22.90 | Evidence | |||||
H3F3A | CREBBP | CREBBP, CBP: CREB-binding protein | 22.40 | Evidence | |||||
H3F3A | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 19.50 | Evidence | |||||
H3F3A | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 17.70 | Evidence | |||||
H3F3A | TP53BP1 | TP53BP1: Tumor suppressor p53-binding protein 1 | 17.60 | Evidence | |||||
H3F3A | HMGN2 | HMGN2, HMG17: Non-histone chromosomal protein HMG-17 | 17.20 | Evidence | |||||
H3F3A | HIST3H3 | HIST3H3, H3FT: Histone H3.1t | 17.10 | Evidence | |||||
H3F3A | ETV6 | ETV6, TEL, TEL1: Transcription factor ETV6 | 17.10 | Evidence | |||||
H3F3A | RELA | RELA, NFKB3: Transcription factor p65 | 16.50 | Evidence | |||||
H3F3A | CHAF1B | CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B | 15.50 | Evidence | |||||
H3F3A | SSRP1 | SSRP1, FACT80: FACT complex subunit SSRP1 | 14.40 | Evidence | |||||
H3F3A | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 14.40 | Evidence | |||||
H3F3A | XRCC6 | XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 | 13.10 | Evidence | |||||
H3F3A | HNRPH3 | HNRPH3: Heterogeneous nuclear ribonucleoprotein H3 | 12.40 | Evidence | |||||
H3F3A | HDAC1 | HDAC1, RPD3L1: Histone deacetylase 1 | 11.70 | Evidence | |||||
H3F3A | C20orf100 | N/A | 10.80 | Evidence | |||||
H3F3A | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 10.80 | Evidence | |||||
H3F3A | NPM3 | NPM3: Nucleoplasmin-3 | 10.40 | Evidence | |||||
H3F3A | NCOA3 | N/A | 10.40 | Evidence | |||||
H3F3A | BARD1 | BARD1: BRCA1-associated RING domain protein 1 | 10.30 | Evidence | |||||
H3F3A | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 10.30 | Evidence | |||||
H3F3A | H2AFZ | H2AFZ, H2AZ: Histone H2A.Z | 10.10 | Evidence | |||||
H3F3A | HIST1H2BG | HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2B | 10.10 | Evidence | |||||
H3F3A | UBE2A | UBE2A, RAD6A: Ubiquitin-conjugating enzyme E2 A | 10.10 | Evidence | |||||
H3F3A | TOP2B | N/A | 9.76 | Evidence | |||||
H3F3A | MARK2 | N/A | 9.76 | Evidence | |||||
H3F3A | TLK1 | TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 | 9.76 | Evidence | |||||
H3F3A | KLF13 | KLF13, BTEB3, NSLP1: Krueppel-like factor 13 | 9.32 | Evidence | |||||
H3F3A | ATAD2 | ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 | 9.29 | Evidence | |||||
H3F3A | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 8.89 | Evidence | |||||
H3F3A | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 8.74 | Evidence | |||||
H3F3A | HIST2H3C | HIST2H3A, HIST2H3C, H3F2, H3FM: Histone H3.2 | 8.49 | Evidence | |||||
H3F3A | NUP43 | N/A | 8.34 | Evidence | |||||
H3F3A | HIST1H2AC | HIST1H2AC, H2AFL: Histone H2A type 1-C | 8.33 | Evidence | |||||
H3F3A | HMGB1 | HMGB1, HMG1: High mobility group protein B1 | 8.01 | Evidence | |||||
H3F3A | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 7.66 | Evidence | |||||
H3F3A | VCP | VCP: Transitional endoplasmic reticulum ATPase | 7.4 | Evidence | |||||
H3F3A | ZNF24 | ZNF24, KOX17, ZNF191, ZSCAN3: Zinc finger protein 24 | 7.10 | Evidence | |||||
H3F3A | AURKA | AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 | 6.63 | Evidence | |||||
H3F3A | MRE11A | MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A | 6.45 | Evidence | |||||
H3F3A | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 6.30 | Evidence | |||||
H3F3A | TRAF2 | TRAF2, TRAP3: TNF receptor-associated factor 2 | 6.04 | Evidence | |||||
H3F3A | KIF22 | KIF22, KID, KNSL4: Kinesin-like protein KIF22 | 5.9 | Evidence | |||||
H3F3A | CHEK2 | CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 | 5.74 | Evidence | |||||
H3F3A | HTATIP | N/A | 5.74 | Evidence | |||||
H3F3A | SMARCA2 | SMARCA2, BRM, SNF2A, SNF2L2: Probable global transcription activator SNF2L2 | 5.74 | Evidence | |||||
H3F3A | RREB1 | RREB1, FINB: RAS-responsive element-binding protein 1 | 5.74 | Evidence | |||||
H3F3A | KIAA0683 | DKFZp434A073, DKFZp434I062, KIAA0683, TELO2, hCG_42688: Putative uncharacterized | 5.74 | Evidence | |||||
H3F3A | CORO1A | CORO1A, CORO1: Coronin-1A | 5.67 | Evidence | |||||
H3F3A | SMAD3 | SMAD3, MADH3: Mothers against decapentaplegic homolog 3 | 5.55 | Evidence | |||||
H3F3A | HIST1H2BH | HIST1H2BH, H2BFJ: Histone H2B type 1-H | 5.48 | Evidence | |||||
H3F3A | ETV1 | ETV1, ER81: ETS translocation variant 1 | 5.28 | Evidence | |||||
H3F3A | GADD45G | GADD45G, CR6, DDIT2: Growth arrest and DNA-damage-inducible protein GADD45 gamma | 5.14 | Evidence | |||||
H3F3A | AAAS | AAAS, ADRACALA, GL003: Aladin | 5.04 | Evidence | |||||
H3F3A | CBX1 | CBX1, CBX: Chromobox protein homolog 1 | 4.64 | Evidence | |||||
H3F3A | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 4.55 | Evidence | |||||
H3F3A | CDK2 | CDK2: Cell division protein kinase 2 | 4.55 | Evidence | |||||
H3F3A | PIK3C2A | PIK3C2A: Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha po | 4.47 | Evidence | |||||
H3F3A | LIG1 | LIG1: DNA ligase 1 | 4.23 | Evidence | |||||
H3F3A | TCF8 | ZEB1, AREB6, TCF8: Zinc finger E-box-binding homeobox 1 | 4.23 | Evidence | |||||
H3F3A | HIST1H2BO | HIST1H2BO, H2BFH, H2BFN: Histone H2B type 1-O | 4.09 | Evidence | |||||
H3F3A | CDK6 | CDK6: Cell division protein kinase 6 | 4.01 | Evidence | |||||
H3F3A | BLM | BLM, RECQ2, RECQL3: Bloom syndrome protein | 4.01 | Evidence | |||||
H3F3A | ARNT | ARNT: Aryl hydrocarbon receptor nuclear translocator | 3.88 | Evidence | |||||
H3F3A | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 3.88 | Evidence | |||||
H3F3A | LOC642558 | FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 | 3.88 | Evidence | |||||
H3F3A | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 3.85 | Evidence | |||||
H3F3A | HMGB2 | HMGB2, HMG2: High mobility group protein B2 | 3.59 | Evidence | |||||
H3F3A | CBX5 | CBX5, HP1A: Chromobox protein homolog 5 | 3.52 | Evidence | |||||
H3F3A | ATXN2L | N/A | 3.47 | Evidence | |||||
H3F3A | SON | 3.47 | Evidence | ||||||
H3F3A | ELMO1 | N/A | 3.47 | Evidence | |||||
H3F3A | ATM | ATM: Serine-protein kinase ATM | 3.47 | Evidence | |||||
H3F3A | SATB1 | SATB1: DNA-binding protein SATB1 | 3.47 | Evidence | |||||
H3F3A | BRD4 | N/A | 3.44 | Evidence | |||||
H3F3A | JDP2 | jdp2, JDP2: Jun dimerization protein 2 | 3.34 | Evidence | |||||
H3F3A | CUTL1 | CUTL1: Homeobox protein cut-like 1 | 3.34 | Evidence | |||||
H3F3A | IRF7 | N/A | 3.34 | Evidence | |||||
H3F3A | AR | AR, DHTR, NR3C4: Androgen receptor | 3.34 | Evidence | |||||
H3F3A | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 3.07 | Evidence | |||||
H3F3A | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 2.99 | Evidence | |||||
H3F3A | C14orf4 | C14orf4, KIAA1865, My039: RING finger protein C14orf4 | 2.99 | Evidence | |||||
H3F3A | SMAD1 | SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 | 2.99 | Evidence | |||||
H3F3A | TRERF1 | TRERF1, BCAR2, RAPA, TREP132: Transcriptional-regulating factor 1 | 2.99 | Evidence | |||||
H3F3A | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 2.99 | Evidence | |||||
H3F3A | EMD | EMD, EDMD, STA: Emerin | 2.94 | Evidence | |||||
H3F3A | E2F1 | E2F1, RBBP3: Transcription factor E2F1 | 2.94 | Evidence | |||||
H3F3A | SIRT1 | SIRT1, SIR2L1: NAD-dependent deacetylase sirtuin-1 | 2.90 | Evidence | |||||
H3F3A | SMARCA5 | SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul | 2.90 | Evidence | |||||
H3F3A | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 2.84 | Evidence | |||||
H3F3A | FABP3 | FABP3, FABP11, MDGI: Fatty acid-binding protein, heart | 2.76 | Evidence | |||||
H3F3A | MMP7 | MMP7, MPSL1, PUMP1: Matrilysin precursor | 2.75 | Evidence | |||||
H3F3A | TK1 | TK1: Thymidine kinase, cytosolic | 2.70 | Evidence | |||||
H3F3A | SNF1LK2 | SNF1LK2, KIAA0781, QIK: Serine/threonine-protein kinase SNF1-like kinase 2 | 2.63 | Evidence | |||||
H3F3A | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 2.63 | Evidence | |||||
H3F3A | CCNB1 | Cyclin B1 | 2.63 | Evidence | |||||
H3F3A | COL1A2 | COL1A2: Collagen alpha-2(I) chain precursor | 2.63 | Evidence | |||||
H3F3A | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 2.54 | Evidence | |||||
H3F3A | ZCCHC3 | ZCCHC3, C20orf99: Zinc finger CCHC domain-containing protein 3 | 2.54 | Evidence |